Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles J. Davis is active.

Publication


Featured researches published by Charles J. Davis.


The American Journal of Surgical Pathology | 2005

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Jonathan I. Epstein; William C. Allsbrook; Mahul B. Amin; Lars Egevad; Sheldon Bastacky; Antonio Lòpez Beltran; Aasmund Berner; Athanase Billis; Liliane Boccon-Gibod; Liang Cheng; Francisco Civantos; Cynthia Cohen; Michael B. Cohen; Milton W. Datta; Charles J. Davis; Brett Delahunt; Warick Delprado; John N. Eble; Christopher S. Foster; Masakuni Furusato; Paul B. Gaudin; David J. Grignon; Peter A. Humphrey; Kenneth A. Iczkowski; Edward C. Jones; Scott Lucia; Peter McCue; Tipu Nazeer; Esther Oliva; Chin Chen Pan

Five years after the last prostatic carcinoma grading consensus conference of the International Society of Urological Pathology (ISUP), accrual of new data and modification of clinical practice require an update of current pathologic grading guidelines. This manuscript summarizes the proceedings of the ISUP consensus meeting for grading of prostatic carcinoma held in September 2019, in Nice, France. Topics brought to consensus included the following: (1) approaches to reporting of Gleason patterns 4 and 5 quantities, and minor/tertiary patterns, (2) an agreement to report the presence of invasive cribriform carcinoma, (3) an agreement to incorporate intraductal carcinoma into grading, and (4) individual versus aggregate grading of systematic and multiparametric magnetic resonance imaging-targeted biopsies. Finally, developments in the field of artificial intelligence in the grading of prostatic carcinoma and future research perspectives were discussed.


The American Journal of Surgical Pathology | 1998

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

Jonathan I. Epstein; Mahul B. Amin; Victor R. Reuter; F. K. Mostofi; Ferran Algaba; William C. Allsbrook; Alberto G. Ayala; Michael J. Becich; Antonio Lòpez Beltran; Lilliane Boccon-Gibód; David G. Bostwick; Christer Busch; Charles J. Davis; John N. Eble; Christopher S. Foster; Masakuni Furusato; David J. Grignon; Peter A. Humphrey; Elia A. Ishak; Sonny L. Johansson; Edward C. Jones; Leopold G. Koss; Howard S. Levin; William M. Murphy; Robert O. Petersen; Andrew A. Renshaw; Jae Y. Ro; Jeffrey R. Ross; Isabell A. Sesterhenn; John R. Srigley

In October 1997, Dr. F.K. Mostofi assembled a group of individuals interested in bladder neoplasia at a meeting in Washington DC. The participants included urologic pathologists, urologists, urologic oncologists, and basic scientists with an interest in bladder neoplasia. The purpose of this meeting was to discuss bladder terminology and make recommendations to the World Health Organization (WHO) Committee on urothelial tumors. Following this meeting, a group of the urologic pathologists who attended the Washington meeting decided to broaden the representation of the group and arranged a meeting primarily of the members of the International Society of Urologic Pathologists (ISUP) at the 1998 United States and Canadian Academy of Pathology Meeting held in Boston. Massachusetts. At this meeting. issues regarding terminology of bladder lesions, primarily neoplastic and putative preneoplastic lesions, were discussed, resulting in a consensus statement. The WHO/ ISUP consensus classification arises from this consensus conference committees recommendations to the WHO planning committee and their agreement with virtually all of the proposals presented herein. 29 The effort involved in reaching such a consensus was often considerable. Many of those involved in this process have compromised to arrive at a consensus. The aim was to develop a universally acceptable classification system for bladder neoplasia that could be used effectively by pathologists, urologists, and oncologists.


The American Journal of Surgical Pathology | 1995

Renal medullary carcinoma: the seventh sickle cell nephropathy

Charles J. Davis; F. K. Mostofi; Isabell A. Sesterhenn

Over the last 22 years, we have encountered 34 examples of a highly aggressive neoplasm with a microscopic morphology that is highly predictive of finding sickled erythrocytes in the tissue. With the exception of one patient, all are believed to have had sickle cell trait or, in one case, hemoglobin SC disease. These 33 patients are the subject of this report and, where their race was known, they were all blacks between the ages of 11 and 39 years. Between the ages of 11 and 24 years, males predominated by 3 to 1. Beyond age 24, however, the tumors occurred equally in men and women. The dominant tumor mass was in the medulla and ranged from 4 to 12 cm in diameter. Mean size was 7 cm; median, 6 cm. Peripheral satellites in the renal cortex and pelvic soft tissues, as well as venous and lymphatic invasion, were usually present. The lesions exhibited a reticular, yolk sac-like, or adenoid cystic appearance, often with poorly differentiated areas in a highly desmoplastic stroma admixed with neutrophils and usually marginated by lymphocytes. The tumors had usually metastasized when first discovered, and none was confined to the kidney at the time of nephrectomy. The mean duration of life after surgery was 15 weeks. These tumors probably arise in the calyceal epithelium in or near the renal papillae, the same site that produces the more familiar picture of unilateral hematuria in patients with sickle cell trait. We have concluded that renal medullary carcinoma represents another example of renal disease associated with sickle cell disorders. The other six are unilateral hematuria, papillary necrosis, nephrotic syndrome, renal infarction, inability to concentrate urine, and pyelonephritis.


Urology | 1986

Cystic renal cell carcinoma

David S. Hartman; Charles J. Davis; Todd Johns; Stanford M. Goldman

Cystic renal cell carcinoma includes any malignant neoplasm of renal tubular epithelium which presents as a fluid-filled mass. Approximately 15 per cent of cases of renal cell carcinoma will be cystic on radiologic and pathologic examination. The clinical features of cystic renal cell carcinoma are similar to those which are solid. The radiographic and pathologic findings of cystic renal cell carcinoma are often more confusing and less specific than the findings of renal cell carcinoma which are predominantly solid. There are four basic pathologic mechanisms resulting in cystic renal cell carcinoma: intrinsic multiloculated growth; intrinsic unilocular growth (cystadenocarcinoma); cystic necrosis; and origin from the epithelial lining of a preexisting simple cyst. There are three basic radiologic patterns of cystic renal cell carcinoma: unilocular cystic mass, multiloculated cystic mass, and discrete mural nodule in a cystic mass. Cystic renal cell carcinoma is often extremely difficult to differentiate from non-neoplastic, benign neoplastic, and other malignant neoplastic masses utilizing radiologic studies alone. This review presents the clinical, pathologic, and radiographic features of cystic renal cell carcinoma and discusses its radiologic differential diagnosis.


Urology | 1979

Atypical carcinoma of kidney: Possibly originating from collecting duct epithelium☆

William J. Cromie; Charles J. Davis; Francis A. Deture

An atypical carcinoma of the kidney with cellular elements of renal cell and transitional cell carcinoma is presented. The unusual histologic features suggest a lesion originating from the collecting duc t epithelium. Evaluation of atypical renal carcinoma as to origin is advocated.


The Journal of Urology | 1997

The microscopic pathology of Peyronie's disease.

Charles J. Davis

PURPOSE All cases of Peyronies disease in the files were reviewed to determine the chief microscopic findings and also to note the anatomical site of the disease process. MATERIALS AND METHODS The microscopic findings in 19 cases were evaluated using hematoxylin and eosin sections, and Masson trichrome was frequently used to highlight alterations of collagen structure. Movat elastic stain and fibrinogen immunostain for fibrin were used in some cases. RESULTS A perivascular lymphocytic infiltrate was found in 6 of the 19 cases, located either within the tunica albuginea or on either side of it. A linear band of ossification was found in the tunica in 5 cases. Disorganization of the collagen of the tunica was present in all cases, usually associated with a slight increase in cellularity. In 3 of 10 cases fibrin was demonstrated in the affected area of the tunica. CONCLUSIONS Peyronies disease is characterized by an alteration in the appearance and cellularity of the collagen that comprises the tunica albuginea. Ossification in the middle or inner aspect of the tunica may occur, and a perivascular lymphocytic infiltrate may or may not be present within the tunica or on either side of it.


Cancer Control | 2004

Pathology of Germ Cell Tumors of the Testis

Isabell A. Sesterhenn; Charles J. Davis

BACKGROUND An increasing incidence of testis tumors has been noted over the second half of the 20th century. Congenital malformation of the male genitalia, prenatal risk factors, nonspecific and specific exposures in adulthood, and male infertility have all been associated with the etiology of germ cell tumors. METHODS The histologic classification, pathology, and current concepts of testicular germ cell tumors are reviewed. RESULTS Germ cell tumors occur at all ages. The tumors are identified as pure form (those of one histologic type) and mixed form (more than one histologic type). Over half of germ cell tumors consist of more than one cell type, requiring appropriate sampling for the correct diagnosis and correlation with the serum tumor markers. Burned-out germ cell tumors may occur in patients with metastatic disease with no gross evidence of a testicular tumor. CONCLUSIONS Appropriate management of testis tumors relies on accurate pathology and classification of these tumors.


The Journal of Urology | 1982

Primary Malignant Renal Tumors in the Second Decade of Life: Wilms Tumor Versus Renal Cell Carcinoma

David S. Hartman; Charles J. Davis; John E. Madewell; Arnold C. Friedman

Primary renal malignancies occur least frequently in the second decade of life. Of the 4,798 cases of renal cell carcinoma and Wilms tumor referred to the Armed Forces Institute of Pathology 53 renal cell carcinomas and 56 Wilms tumors occurred in the 10 to 20-year age group. Pathologically, both tumors in this age range are similar to those occurring at a more typical age, and histologic differentiation between renal cell carcinoma and Wilms tumor is seldom a problem. While radiographic evaluation is useful to characterize the neoplasm, evaluate the contralateral kidney and detect the presence of tumor extension, current imaging techniques cannot confidently distinguish these 2 tumors.


The American Journal of Surgical Pathology | 2004

Epithelioid hemangioma of the penis: a clinicopathologic and immunohistochemical analysis of 19 cases, with special reference to exuberant examples often confused with epithelioid hemangioendothelioma and epithelioid angiosarcoma.

John F. Fetsch; Isabell A. Sesterhenn; Markku Miettinen; Charles J. Davis

Epithelioid hemangiomas of the penis are very rare. To date, less than 10 examples have been reported in the English language literature. In this report, we describe the clinical, histopathologic, and immunohistochemical findings in 19 cases retrieved from our files. The patients ranged in age from 23 to 75 years (median age, 45 years) at the time of initial surgical resection. Seventeen patients presented with a solitary mass, and two presented with two separate, but closely approximated, lesions. The process involved the glans penis (n = 3), shaft (n = 11), base of the penis (n = 2), or penis, not otherwise specified (n = 3). The lesions ranged in size from <0.5 to 2.5 cm (median size, ∼1.2 cm) in greatest dimension. Eleven examples were specifically noted to be dorsally located, and only one was stated to be ventral. Localized pain or tenderness was the most common complaint, documented in 12 cases. The preoperative duration of the lesions ranged from 5 days to 1 year (median 4.5 months). Microscopically, all examples contained a tumefactive proliferation of epithelioid endothelial cells, often in a nodular or lobular configuration and associated with an inflammatory infiltrate containing lymphocytes and eosinophils. In 14 cases, the vascular proliferation was associated with a small arterial segment, sometimes with mural damage and frequently (n = 13) with intraluminal epithelioid endothelial cells. Based on the growth pattern of the epithelioid endothelial cells, 13 cases were considered “typical,” and six were considered exuberant or “atypical.” The latter examples had a prominent centrally located zone where nests or sheet-like aggregates of epithelioid endothelial cells did not form discrete vessels. Immunohistochemical data are available for 15 tumors. The epithelioid endothelial cells usually had strong reactivity for CD31, lesser reactivity for factor VIIIrAg, and minimal reactivity for CD34. In 9 of 12 cases, a small number of epithelioid endothelial cells expressed keratins. In all cases tested, at least focal muscle-specific actin-positive myopericytic cells were present bordering the endothelial cells, and this was especially notable peripherally. Initial surgical intervention consisted of either a shave biopsy (n = 1), excisional biopsy (n = 2), or local excision (n = 16). A complete follow-up history is available for 12 patients, and incomplete follow-up information is available for an additional four patients. One patient developed a new epithelioid hemangioma at a site within the penis separate from the initial lesion, but no patient is known to have experienced a true metastasis or to have died of complications of this process. Optimal management appears to be complete local excision with periodic follow-up visits to monitor for local recurrence.


Modern Pathology | 2006

Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases.

Charles J. Davis; Joel Barton; Isabell A. Sesterhenn

This report deals with 11 examples of renal angiomyolipomas (AML) which appear to include an epithelial element as a part of the neoplasm in the form of gross or microscopic cysts—usually both. There were seven females and four males between the ages of 20 and 70 years with mean age of 45 years. Three of these were known to be symptomatic: intermittent flank pain and gross hematuria for 2 months; recurrent hematuria both before and after flank trauma and a third patient with acute abdomen due to a ruptured tumor blood vessel. Cysts were described in three of the six cases where radiographic data were available. Seven tumors were in the right kidney and four in the left. In gross descriptions, cysts were mentioned in seven and they ranged from 6.0 to 2.0 cm with a median and mean maximal diameter of 5.0 and 4.0 cm, respectively. Microscopically, virtually all of the tumors included multiple smaller cysts and these were lined by flat, cuboidal or columnar epithelium and occasionally hobnail epithelium. There was usually a subepithelial collar of poorly differentiated cells, but the solid element of all tumors was myomatous angiomyolipoma; only one case had any adipose tissue. A dominant histological feature was the prominent lymphatic channels—identical to those of lymphangiomyomas and myomatous or triphasic AMLs. They are much more conspicuous in these cystic cases. Immunohistochemically, all tumors tested were reactive with actin, desmin and HMB-45, with the latter being more intensely positive in the subepithelial collars. Estrogen and progesterone receptors were usually positive, also. The behavior of these lesions appears to be no different from that of other AMLs.

Collaboration


Dive into the Charles J. Davis's collaboration.

Top Co-Authors

Avatar

F. K. Mostofi

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

David S. Hartman

Penn State Milton S. Hershey Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John E. Madewell

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

John F. Fetsch

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

David G. McLeod

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Bungo Furusato

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Joel E. Lichtenstein

Armed Forces Institute of Pathology

View shared research outputs
Top Co-Authors

Avatar

Bungo Furusato

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

David S. Feigin

Armed Forces Institute of Pathology

View shared research outputs
Researchain Logo
Decentralizing Knowledge